Epidemics and Pandemics 04/27/20

Epidemics and Pandemics 04/27/20

Baran Group Meeting Dongmin Xu Epidemics and Pandemics 04/27/20 Timeline of some major epidemics/pandemics in human history Quick facts: • From wikipedia: • An epidemic is the rapid spread of a disease to a large number of ~ 400 BC Plague of Athens (Greece, possibly typhus) people in a given population within a short period of time. 165-180 Antonine Plague (Roman Empire, possibly smallpox) • A pandemic is a serious epidemic that has spread over a large region and/or affects a substantial number of people. 250-266 Plague of Cyprian (Europe, possibly smallpox) • The most fatal pandemic in human history was the Black Death, which resulted in an estimated 75-200 million deaths (1/3 of European population) 541-542 Plague of Justinian (Europe, plague) • Major diseases that were responsible for outbreaks: • Medication available: plague, tuberculosis, influenza, malaria, cholera, 735-737 Japanese smallpox epidemic (Japan, smallpox) leprosy, AIDS/HIV • Only vaccines: measles, smallpox, typhus, yellow fever, Ebola 1300s Black Death (Europe, plague) • No treatments available: coronavirus (SARS, MERS, COVID-19) 1600s Italian plague (Italy, plague) Compartment model in epidemiology: • The simplest model for a disease outbreak is the SIR model, where: Great plague of London (England, plague) • S = number of Susceptibles • I = number of Infected Great plague of Vienna (Austria, plague) • R = number of Recovered (or deceased) S, I and R are all functions with respect to time t susceptible Great plague of Marseille (France, plague) recovered 1700s • Rates of change for S, I, and R: Persian plague (Persia, plague) (β = avg. number of social encounters, I/N = avg. prob. of encoutering a patient) 1800s Ottoman plague epidemic (Ottoman empire, plague) infected (γ = the rate at which patients recover/die) 1st, 2nd and 3rd cholera pandemic (worldwide, cholera) http://jsxgraph.uni-bayreuth.de/wiki/ 1889-1890 flu pandemic (worldwide, influenza) index.php/Epidemiology:_The_SIR_model 1900s Manchurian plague (China, Pneumonic plague) • Controlling the infected curve is crucial to pandemic management https://en.wikipedia.org/ Spanish flu (worldwide, influenza) wiki/Pandemic Asian flu (worldwide, influenza) • Containment • Mitigation Hong Kong flu (worldwide, influenza) • Suppression HIV/AIDS pandemic (worldwide, HIV/AIDS) 2000s 2004-04 SARS outbreak (worldwide, SARS) • The basic reproduction number (R0): the expected number of cases generated by one case in a population where all individuals are still susceptible. 2009 flu pandemic (worldwide, influenza) • Not to be confused with the effective reproduction number (R) Measles 12-18 • When R > 1, the disease spreads 2012 MERS outbreak (worldwide, MERS) Chickenpox 10-12 • When R < 1, the outbreak is under controll and will die out Rubella 5-7 • Importance of vaccination: decrease R (herd immunity) Ebola virus epidemic (west Africa, Ebola) Smallpox 3.5-6 This GM covers: Zika virus epidemic (worldwide, Zika virus) COVID-19 1.4-5.7 • Basic information of epidemics/pandemics HIV/AIDS 2-5 • Several viral epidemics (influenza, HIV, coronavirus) present 2019-20 coronavirus pandemic (worldwide, COVID-19) Common cold 2-3 • Associated antiviral drugs and their synthesis Influenza (1918) 1.4-2.8 = over 100,000 deaths Not covered: Seasonal flu 0.9-2.1 • Bacterial or parasitic diseases = over 1 million deaths • Antibiotics Baran Group Meeting Dongmin Xu Epidemics and Pandemics 04/27/20 https://www.cdc.gov/flu/about/index.html Influenza Virus: https://micro.magnet.fsu.edu/cells/ Influenza viruses/influenzavirus.html • An infectious respiratory disease caused by the influenza virus • Belongs to orthomyxoviridae, a family • Common symptoms include high fever, runny nose, sore throat, muscle and joint pain, of RNA viruses • Four distinct genera: A, B, C, and D headache, coughing, and fatigue • Some structural charateristrics: • Shares many symptoms with common cold. However, common cold is mostly caused • Lipid envelop by human rhinovirus and its symptoms are usually milder. (why rubbing alcohol disinfects) • A yearly outbreak pattern: October to May considered flu season in the US • Nucleoprotein: 8 pieces of single- • 300k - 650k deaths annually; over 3 million cases of severe illness stranded RNA packed with proteins • On average, about 8% of the U.S. population gets flu every season • Hemagglutinin (HA) and neuraminidase • Pandemic severity index (PSI): a level 1 to 5 scale for severity of influenza pandemics (NA): important surface glycoproteins for based on the case fatality rate. Level 5 has the highest case fatality rate of >2.0%. host cell recognition and viral replication. Also the major antigens to trigger immune responses. Pandemic History: J. Appl. Microbiol. 2001, 91, 572–579 Serotypes: • First confirmed record of an influenza epidemic dates back to 1500s • Antigenic shift: mutations and reassortments of viral strains can lead to structural • Responsible for several major outbreaks since the 20th century changes in HA and NA, resulting in different antigenic properties. Case Pandemic • Only observed in influenza A viruses Name Date Deaths fatality rate severity index • Influenza A serotypes are denoted as HxNy • x and y are arbitrary numbers denoting the types of HA and NA 1918 flu pandemic • A total of 18 different types of HA and 11 different types of NA were identified (Spanish flu) 1918-1919 17-50 million 2-3% 5 • Out of the 198 possible permutations, 131 serotypes were found in nature Asian Flu 1957-1958 1-1.5 million 0.13% 2 • Trivia: match the influenza serotype with the corresponding epidemics/pandemics Hong Kong Flu 1968-1969 0.75-1 million <0.1% 2 2009 swine flu H1N1 2009 flu pandemic 2004 avian flu/bird flu (swine flu) 2009-2010 100k - 400k 0.03% N/A H2N2 1968 Hong Kong flu H3N2 The 1918 Flu Pandemic: Emerg Infect Dis. 2006, 12, 15–22. • Origin was disputed; hypotheses include Kansas or European troops in WWI 1957 Asian flu H5N1 • Around 500 million people were infected globally, around 1/3 of the world’s population 1918 Spanish Flu H7N9 • A unique (and not explained) feature is the high mortality rate among young adults • Public places were closed and quarantines were enforced; “social distancing” Mechanism of Action: Front. Immunol. 2018, 9, 1581 • Mutation of the virus was observed between the “waves” • Transmission usually occurs through aerosols (coughs, sneezes, etc.), less commonly of outbreaks through saliva, bodily fluids and feces. • Massive troop movements during WWI likely accelerated • Step 1: Viral HA binds to the epithelial cell, causing the the pandemic and selected for more virulent strains. virus being imported by endocytosis • Died out quickly in early 1919 • Step 2: Viral RNA and RNA polymerases are • Genetic mapping of the virus made possible after Johan released into the cytoplasm and relocate Hultin’s discovery of body samples stored in the permafrost to the nucleus. near Brevig Mission, a remote Alaskan village • Step 3: RNA replication in the nucleus (https://www.cdc.gov/flu/pandemic-resources/reconstruction-1918-virus.html) • Step 4: Viral mRNA re-enters the cyto- plasm and is translated by ribosomes • Step 5: Viral proteins are transported to the cell membrane (HA and NA) or stay the cytoplasm for inhibition of normal cell activity • Step 6: Viral RNA and proteins aggregates near the cell membrane and forms a protusion • Step 7: The new virus detaches (facilitated by NA) by exocytosis, usually followed by death of host cell (https://en.wikipedia.org/ wiki/Orthomyxoviridae) Baran Group Meeting Dongmin Xu Epidemics and Pandemics 04/27/20 OH O O Clin. Microbiol Rev. 2016, 29, 695–747 All Approved Antiviral Drugs for Influenza: For a useful review of viral NA inhibitors, see: O O Molecules 2016, 21, 1513 HO OH Me OEt NH2 OH HN Me HN F HN NH2 NH2 Me O Me O S F NH Oseltamivir (Tamiflu®) ® O ® Amantadine (Symmetrel ) Zanamivir (Relenza ) Gilead, FDA Approv. 1999 FDA Approv. 1968 F N GSK, FDA Approv. 1999 O H NH2 N N O OMe O NH OH N OH Me NH O N 2 ® HO OH H N O Favipiravir (Avigan ) 2 N OH Toyama Chemical OH H MeO O O O Approv. 2014 (Japan) HN Me NH HN NH2 O Me O Baloxavir marboxil (Xofluza®) ® Me O Me Rimantadine (Flumadine ) NH Shionogi & Roche, FDA Approv. 2018 FDA Approv. 1994 Laninamivir (Inavir®) Peramivir (Rapivab®) Daiichi Sankyo, Approv. 2010 (Japan) BioCryst, FDA Approv. 2014 M.2 protein inhibitors RNA polymerase inhibitor Neuroaminidase (NA) inhibitors Cap-dependent endonuclease inhibitor Selected Syntheses: First Synthesis by von Itzstein: OAc OH OH + O CO2Et OH O OH EtOH, H OH Ac O, AcOH AcO TMSN3, tBuOH O 80°C O 2 HO HO 80 °C O CO2H CO2Et OAc HO OH OH 93% OH 72% N 85% AcHN AcHN OH O HN OH OH OAc Me N-acetylneuraminic acid ($47/g) HN NH2 Me O O CO2Et 1) KOH OAc 1) H2, Lindlar cat. AcO NH O CO Et 2) TFA Zanamivir 2 NBoc OAc Zanamivir AcO 2) AcHN Shibasaki’s Synthesis: OAc (6 steps, 30%-50% overall) AcHN MeS NHBoc HN NBoc NO HgCl2, Et3N 2 N3 NHBoc + 85% over 2 steps Carbohydr. Res. 1994, 259, 301–305. PMBO CHO Nd5O(OiPr)13 NaHMDS OBn OTBS 1) OsO OBn OTBS CO2Me -60 °C, 71% OH 10 steps 4 2) NaIO (next page) 3% of: iPr BnO 4 BnO O H OH PMBO OTBS HO N 3) Wittig N NO 22% overall OBn NHAc OBn NHAc H O 2 F F Angew. Chem. Int. Ed. 2012, 51, 1644–1647 Baran Group Meeting Dongmin Xu Epidemics and Pandemics 04/27/20 O OAc 1) H , Pd/C OBn 2 1) Bu NF, AcOH 2) Ac O OAc Ph O CO2Et 4 2 O AcO 2) BF •OEt O CO2Me 79% over 4 steps Ac2O, AcOH 3 2 O CO2Me OAc BnO AcO Zanamivir OBn 3) PhCO2tBu N same steps as CuBr, reflux OAc AcHN AcHN O von Itzstein et al Me Me Ma’s synthesis: Me 20 mol% cat.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    10 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us